Management options rearranged: ROS1 positive lung cancers
Main Authors: | Arvind Krishnamurthy, Vijayalaxmi Ramshankar, Manikandan Venkatasubramaniyan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Cancer Research, Statistics, and Treatment |
Online Access: | http://www.crstonline.com/article.asp?issn=2590-3233;year=2022;volume=5;issue=4;spage=774;epage=775;aulast=Krishnamurthy |
Similar Items
-
Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer
by: Brigida Stanzione, et al.
Published: (2023-07-01) -
TARGETED THERAPY OF LUNG CANCER WITH THE ROS1 REARRANGEMENT
by: K. K. LAKTIONOV, et al.
Published: (2017-06-01) -
Progress of non-small-cell lung cancer with ROS1 rearrangement
by: Xin Yang, et al.
Published: (2023-12-01) -
Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease
by: Daniele Marinelli, et al.
Published: (2022-10-01) -
“Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer”
by: Anne Pernille Harlem Dyrbekk, et al.
Published: (2023-05-01)